|
281 |
First-Line Disease-Modifying Therapies in Paediatric Multiple Sclerosis
Enthalten in Drugs Bd. 72, 6.1.2012, Nr. 9, date:9.2012: 1195-1211
|
|
|
|
282 |
Flagellate Dermatitis as a Bleomycin-Specific Adverse Effect of Cytostatic Therapy
Enthalten in American journal of clinical dermatology Bd. 12, 10.9.2012, Nr. 1, date:2.2011: 68-76
|
|
|
|
283 |
Flucloxacillin and Diclofenac do not Cause Recurrence of Neuromuscular Blockade after Reversal with Sugammadex
Enthalten in Clinical drug investigation Bd. 32, 29.8.2012, Nr. 3, date:3.2012: 203-212
|
|
|
|
284 |
Fluoroquinolone-Associated Myasthenia Gravis Exacerbation
Enthalten in Drug safety Bd. 34, 3.1.2013, Nr. 10, date:10.2011: 839-847
|
|
|
|
285 |
Fluoroquinolones in Community-Acquired Pneumonia
Enthalten in Drugs Bd. 71, 18.11.2012, Nr. 6, date:4.2011: 757-770
|
|
|
|
286 |
Food Effects on the Pharmacokinetics of Doxylamine Hydrogen Succinate 25 mg Film-Coated Tablets
Enthalten in Drugs in R & D Bd. 12, 23.12.2012, Nr. 4, date:12.2012: 217-225
|
|
|
|
287 |
Foreword
Enthalten in CNS drugs Bd. 25, 30.8.2012, Nr. 1, date:12.2011: 1-2
|
|
|
|
288 |
Foreword
Enthalten in BioDrugs Bd. 24, 16.8.2012, Nr. 1, date:12.2010: 1-2
|
|
|
|
289 |
Foreword
Enthalten in American journal of clinical dermatology Bd. 12, 21.8.2012, Nr. 1, date:9.2011: 1-2
|
|
|
|
290 |
Foreword
Enthalten in Clinical drug investigation Bd. 30, 17.9.2012, Nr. 1, date:4.2010: 1-2
|
|
Administration
